2022 | Health Technology Assessment Division

Evidence brief for 29 October to 04 November 2022

Posted on November 7, 2022

For the period of 29 October 2022 to 04 November 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 29 October – 04 November 2022 Document Preview:

[Department Circular No. 2022 – 0580] Release of the Final Priority List of HTA Topics for 2022 That Will Proceed to Topic Assessment

Posted on November 7, 2022

Evidence brief for 22 to 28 October 2022

Posted on November 4, 2022

For the period of 22 to 28 October 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 22 – 28 October 2022 Document Preview:

[Department Circular No. 2022 – 0560] Health Technology Assessment Council (HTAC) Recommendation for the Inclusion of Zoledronic Acid for Individuals with Malignancy-Related Bone Disease in the Philippine National Formulary (PNF)

Posted on October 28, 2022

View Post

Evidence brief for 15 to 21 October 2022

Posted on October 26, 2022

For the period of 15 to 21 October 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 15 – 21 October 2022 Document Preview: